BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Immunic, Inc. annonce ses résultats financiers du premier trimestre 2024 et des mises à jour sur l'entreprise Stratégie Financière Immunic Inc Rapport Financier Du Premier Trimestre 2024 Essais Sur La Sclérose En Plaques Traitement De La Maladie Coeliaque
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Zomedica to Participate in EF Hutton Annual Global Conference Zomedica Veterinary Health Investor Meetings EF Hutton Conference NYSE American:ZOM
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Zomedica participera à la conférence mondiale annuelle d'EF Hutton Zomedica Santé Vétérinaire Réunions D'investisseurs Conférence EF Hutton NYSE Américain : ZOM
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago NanoViricides Announces Promising Results with NV-387 in Potentially Treating Smallpox and Mpox NanoViricides NV-387 Tecovirimat Smallpox Mpox
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago NanoViricides annonce des résultats prometteurs avec le NV-387 dans le traitement potentiel de la variole et de la Mpox NanoViricides NV-387 Tecovirimat Variole Mvariole
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
BRIEF published on 05/08/2024 at 12:20, 1 year 10 months ago Holcim Shareholders Approve Proposals at 2024 AGM Corporate Governance Dividend Increase Board Elections Shareholder Approvals Holcim AGM 2024
BRIEF published on 05/08/2024 at 12:20, 1 year 10 months ago Les actionnaires de Holcim approuvent les propositions lors de l'AGA 2024 Gouvernance D'Entreprise Augmentation Du Dividende Élections Du Conseil D'administration Approbations Des Actionnaires Assemblée Générale Holcim 2024
BRIEF published on 05/08/2024 at 12:05, 1 year 10 months ago Cannovation Clinical Research Partners Launches, Aiming to Revolutionize Cannabinoid-Based Therapeutics Drug Development Biopharmaceutical Innovation Cannovation Clinical Research Cannabinoid-based Therapeutics Commercialization Strategies
Published on 03/13/2026 at 14:00, 2 hours 46 minutes ago CCL Industries Signs Agreement to Acquire Sleever International
Published on 03/13/2026 at 13:30, 3 hours 16 minutes ago Zentek Ltd. Receives Favorable Judgment in Long-Standing Litigation
Published on 03/13/2026 at 13:30, 3 hours 16 minutes ago Sky Gold Engages Drill Company for Upcoming Program on Its Evening Star Property, Walker Lane Trend, Nevada
Published on 03/13/2026 at 12:30, 4 hours 16 minutes ago Hans Vestberg Co-Founds Next Phase of US Data Centers Inc. with Digi Power X to Deploy Modular AI Infrastructure at Scale
Published on 03/13/2026 at 12:30, 4 hours 16 minutes ago Battery X Metals Announces Equity Incentive Grants
Published on 03/13/2026 at 15:45, 1 hour ago Original-Research: Reply SpA (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 03/13/2026 at 15:36, 1 hour 10 minutes ago EQS-Adhoc: Enapter AG: Enapter AG Publishes Preliminary Figures for 2025
Published on 03/13/2026 at 15:22, 1 hour 23 minutes ago Edison issues report on Finsbury Growth & Income Trust (FGT)
Published on 03/13/2026 at 15:16, 1 hour 30 minutes ago EQS-Adhoc: Fraport AG Frankfurt Airport Services Worldwide: Dividend Forecast
Published on 03/13/2026 at 15:15, 1 hour 30 minutes ago EQS-Adhoc: Finexity AG: FINEXITY AG publishes preliminary financial results for 2025 and provides outlook for fiscal year 2026
Published on 03/13/2026 at 07:30, 9 hours 16 minutes ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/13/2026 at 07:30, 9 hours 16 minutes ago BIOPHYTIS PRÉSENTE SES PROGRAMMES DE DÉVELOPPEMENT DANS L’OBÉSITÉ ET LA SARCOPÉNIE AU CONGRÈS ICFSR
Published on 03/12/2026 at 18:30, 22 hours 16 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 03/12/2026 at 18:30, 22 hours 16 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 03/12/2026 at 18:30, 22 hours 16 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES FÉVRIER 2026
